BlackRock’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$192M Sell
21,425,849
-1,343,397
-6% -$12M ﹤0.01% 1626
2025
Q1
$171M Buy
22,769,246
+674,083
+3% +$5.06M ﹤0.01% 1675
2024
Q4
$166M Buy
22,095,163
+1,179,192
+6% +$8.87M ﹤0.01% 1757
2024
Q3
$159M Buy
20,915,971
+959,716
+5% +$7.29M ﹤0.01% 1780
2024
Q2
$123M Buy
19,956,255
+1,515,526
+8% +$9.37M ﹤0.01% 1894
2024
Q1
$93.7M Sell
18,440,729
-240,641
-1% -$1.22M ﹤0.01% 2062
2023
Q4
$112M Buy
18,681,370
+1,907,066
+11% +$11.4M ﹤0.01% 1978
2023
Q3
$119M Buy
16,774,304
+1,278,601
+8% +$9.05M ﹤0.01% 1876
2023
Q2
$109M Buy
15,495,703
+670,905
+5% +$4.72M ﹤0.01% 1970
2023
Q1
$124M Sell
14,824,798
-94,157
-0.6% -$785K ﹤0.01% 1856
2022
Q4
$171M Buy
14,918,955
+1,143,960
+8% +$13.1M 0.01% 1644
2022
Q3
$174M Sell
13,774,995
-212,423
-2% -$2.68M 0.01% 1571
2022
Q2
$148M Sell
13,987,418
-114,557
-0.8% -$1.21M ﹤0.01% 1737
2022
Q1
$229M Sell
14,101,975
-685,420
-5% -$11.1M 0.01% 1569
2021
Q4
$205M Sell
14,787,395
-543,463
-4% -$7.53M 0.01% 1714
2021
Q3
$220M Sell
15,330,858
-150,469
-1% -$2.16M 0.01% 1629
2021
Q2
$245M Sell
15,481,327
-760,448
-5% -$12M 0.01% 1613
2021
Q1
$165M Sell
16,241,775
-17,970
-0.1% -$183K ﹤0.01% 1842
2020
Q4
$121M Buy
16,259,745
+315,852
+2% +$2.35M ﹤0.01% 1940
2020
Q3
$54.8M Buy
15,943,893
+1,276,979
+9% +$4.39M ﹤0.01% 2196
2020
Q2
$69.9M Buy
14,666,914
+1,271,297
+9% +$6.06M ﹤0.01% 2049
2020
Q1
$26.8M Buy
13,395,617
+1,245,406
+10% +$2.49M ﹤0.01% 2419
2019
Q4
$41.9M Buy
12,150,211
+2,555,431
+27% +$8.82M ﹤0.01% 2450
2019
Q3
$27.5M Buy
9,594,780
+668,889
+7% +$1.92M ﹤0.01% 2610
2019
Q2
$33.8M Buy
8,925,891
+228,525
+3% +$866K ﹤0.01% 2528
2019
Q1
$70.8M Sell
8,697,366
-152,061
-2% -$1.24M ﹤0.01% 2076
2018
Q4
$71.4M Buy
8,849,427
+79,571
+0.9% +$642K ﹤0.01% 2018
2018
Q3
$66.9M Buy
8,769,856
+1,013,905
+13% +$7.74M ﹤0.01% 2208
2018
Q2
$44.4M Buy
7,755,951
+281,532
+4% +$1.61M ﹤0.01% 2415
2018
Q1
$35.7M Sell
7,474,419
-139,861
-2% -$667K ﹤0.01% 2454
2017
Q4
$37.4M Buy
7,614,280
+993,100
+15% +$4.88M ﹤0.01% 2436
2017
Q3
$34.7M Buy
6,621,180
+362,803
+6% +$1.9M ﹤0.01% 2473
2017
Q2
$34.8M Buy
6,258,377
+244,100
+4% +$1.36M ﹤0.01% 2443
2017
Q1
$50.5M Buy
6,014,277
+6,004,070
+58,823% +$50.4M ﹤0.01% 2202
2016
Q4
$65K Buy
10,207
+231
+2% +$1.47K ﹤0.01% 2740
2016
Q3
$44K Sell
9,976
-6,699
-40% -$29.5K ﹤0.01% 2961
2016
Q2
$48K Buy
16,675
+11,883
+248% +$34.2K ﹤0.01% 2909
2016
Q1
$14K Buy
4,792
+2,769
+137% +$8.09K ﹤0.01% 2953
2015
Q4
$21K Buy
2,023
+551
+37% +$5.72K ﹤0.01% 2506
2015
Q3
$17K Sell
1,472
-58,800
-98% -$679K ﹤0.01% 2445
2015
Q2
$900K Sell
60,272
-3,345
-5% -$49.9K ﹤0.01% 1377
2015
Q1
$575K Hold
63,617
﹤0.01% 1477
2014
Q4
$774K Hold
63,617
﹤0.01% 1241
2014
Q3
$622K Sell
63,617
-4,300
-6% -$42K ﹤0.01% 1278
2014
Q2
$866K Buy
67,917
+67,903
+485,021% +$866K ﹤0.01% 1209
2014
Q1
$0 Buy
+14
New ﹤0.01% 3100